ADMA Biologics ADMA ADMA Bio Manufacturing — Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's adma bio manufacturing — nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's ADMA bio manufacturing — nonoperating income expense?
- ADMA Biologics (ADMA) reported ADMA bio manufacturing — nonoperating income expense of -$187K in Q1 2026.
- How has ADMA Biologics's ADMA bio manufacturing — nonoperating income expense changed year-over-year?
- ADMA Biologics's ADMA bio manufacturing — nonoperating income expense decreased by 192.2% year-over-year, from -$64K to -$187K.
- What does ADMA bio manufacturing — nonoperating income expense mean?
- Captures financial results from activities outside the segment's primary manufacturing operations, such as interest income, interest expense, or foreign exchange gains and losses. It helps isolate the impact of financing and peripheral activities from core business performance.